The library contains human dermatology and surgery textbooks — not veterinary resources. The query is specifically about a dog with a growth below the nail (subungual/periungual mass in a canine). This is a veterinary medicine question, and the textbooks here don't cover veterinary oncology or small animal medicine. I'll provide a comprehensive answer from clinical veterinary knowledge.
Subungual/Periungual Growth in Dogs — Treatment Protocol
A growth below or around the nail (claw) in a dog is a serious finding. The digit/nail area is one of the most common sites for tumors in dogs, and the approach depends heavily on the type of growth.
Step 1 — Diagnosis First (Critical)
Before any treatment, proper diagnosis is essential. The most common causes of subungual/periungual masses in dogs include:
| Type | Key Features |
|---|
| Squamous Cell Carcinoma (SCC) | Most common digit tumor in dogs; often large breeds (black Labradors, Standard Poodles, Giant Schnauzers); bone lysis on X-ray |
| Melanoma | Aggressive; common in dark-pigmented breeds; high metastatic rate |
| Mast Cell Tumor | Variable behavior; must be graded histologically |
| Infundibular cyst / keratoacanthoma | Benign; slow growing |
| Fibromatous epulis / fibroma | Benign; soft tissue only |
| Onychomatricoma | Rare benign nail matrix tumor |
| Bacterial/fungal paronychia | Infectious, not a true neoplasm |
| Nail bed abscess | Painful swelling, discharge |
Diagnostic workup:
- Fine needle aspirate (FNA) — quick cytology to screen for round cell tumors (mast cell, melanoma)
- Incisional or excisional biopsy with histopathology — definitive diagnosis
- Digital radiographs (X-ray) — assess bone (P3 = third phalanx) involvement; SCC typically causes lytic bone destruction
- Thoracic radiographs — 3 views for metastasis screening (especially for melanoma and SCC)
- Regional lymph node assessment — palpation ± FNA of popliteal or inguinal lymph nodes
Step 2 — Staging
Based on the World Health Organization (WHO) staging for canine digit tumors:
- Stage I: Tumor confined to digit, no bone involvement
- Stage II: Bone (P3) involvement, no metastasis
- Stage III: Regional lymph node metastasis
- Stage IV: Distant metastasis
Step 3 — Treatment Protocol by Diagnosis
A. Malignant Tumors (SCC, Melanoma, MCT)
Surgical treatment — Digit amputation is the standard of care
| Extent | Procedure |
|---|
| P3 only involved | Amputation at the P2-P3 joint (distal phalanx amputation) |
| P2 involved | Amputation at P1-P2 joint |
| Extensive / soft tissue spread | Amputation of entire digit at metacarpal/metatarsal level |
- Dogs tolerate digit amputation extremely well and maintain full ambulation.
- Provides clean surgical margins and is often curative for localized SCC.
- Submit the entire amputated digit for histopathology to confirm margins.
Adjuvant therapy:
| Tumor Type | Adjuvant Treatment |
|---|
| SCC | Radiation therapy if incomplete margins; Piroxicam (0.3 mg/kg PO q24h with food) as COX-2 inhibitor adjunct |
| Melanoma | Canine melanoma vaccine (Oncept, Merial) — licensed USDA conditionally; ideally combined with surgery; Carboplatin or dacarbazine if metastatic |
| Mast Cell Tumor | Grade-dependent; Toceranib (Palladia) or Masitinib for c-KIT mutant MCT; prednisone + vinblastine/CCNU for intermediate/high grade |
B. Benign Growths (Cysts, Fibromas, Keratoacanthoma)
- Surgical excision with wide local margins is usually curative.
- Digit amputation is generally not required if bone is uninvolved.
- Monitor for recurrence.
C. Infectious (Paronychia, Abscess)
- Culture and sensitivity of discharge
- Systemic antibiotics (e.g., Amoxicillin-clavulanate 12.5–25 mg/kg PO q12h; or based on C&S)
- Antifungals if fungal paronychia suspected (e.g., Itraconazole 5 mg/kg PO q24h)
- Local wound care: soaking in dilute chlorhexidine (0.05%) solution BID
- If chronic/non-responsive: surgical debridement or partial nail removal
Step 4 — Post-Operative / Supportive Care
- E-collar (Elizabethan collar) to prevent licking/chewing
- Bandaging the foot for 7–14 days post-amputation
- NSAIDs for pain: Carprofen (2.2 mg/kg PO q12h), Meloxicam (0.1 mg/kg PO q24h), or Gabapentin for neuropathic pain
- Recheck at 7–14 days for suture removal and wound assessment
- Oncology follow-up at 1, 3, and 6 months post-surgery with chest X-rays if malignant tumor confirmed
Prognosis Summary
| Tumor Type | Prognosis |
|---|
| SCC (digit, no metastasis) | Good — median survival >2 years with digit amputation |
| Melanoma (digit) | Guarded — high metastatic rate; median survival ~1 year with surgery + vaccine |
| MCT (low grade) | Good with surgery |
| MCT (high grade) | Poor without adjuvant chemotherapy |
| Benign cyst/fibroma | Excellent |
Key Takeaway
Do not delay — a growth at the base of or beneath a dog's nail should be evaluated by a veterinarian promptly. Digit SCC in dogs frequently causes bone destruction and can be mistaken for osteomyelitis. Early digit amputation for malignant tumors is associated with significantly better outcomes than delayed surgery.
Refer to a veterinary oncologist if the mass is histologically confirmed as melanoma, high-grade MCT, or if there is evidence of lymph node or pulmonary metastasis.